0001567619-20-020225.txt : 20201123 0001567619-20-020225.hdr.sgml : 20201123 20201123170443 ACCESSION NUMBER: 0001567619-20-020225 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201120 FILED AS OF DATE: 20201123 DATE AS OF CHANGE: 20201123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zhen Marianne CENTRAL INDEX KEY: 0001750085 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 201338723 MAIL ADDRESS: STREET 1: C/O INNOVIVA, INC. STREET 2: 2000 SIERRA POINT PARKWAY, SUITE 500 CITY: BRISBANE STATE: CA ZIP: 94005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Innoviva, Inc. CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 500 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 6502389600 MAIL ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 500 CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: THERAVANCE INC DATE OF NAME CHANGE: 20020207 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 4 1 doc1.xml FORM 4 X0306 4 2020-11-20 0 0001080014 Innoviva, Inc. INVA 0001750085 Zhen Marianne 1350 OLD BAYSHORE HIGHWAY, SUITE 400 BURLINGAME CA 94010 0 1 0 0 Chief Accounting Officer Common Stock 2020-11-20 4 F 0 798 10.95 D 30202 D The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity grants. Includes 757 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan (ESPP) on November 15, 2020. /s/ Marianne Zhen 2020-11-23